Skip to main content

PUBLICATIONS

Nanoliposomal irinotecan plus fluorouracil and folinic acid in irinotecan-pretreated vs. -naive pancreatic cancer patients: A retrospective cohort study

Posterbeitrag DGHO 2021

CURRENT TREATMENT LANDSCAPE OF PANCREATIC CANCER PATIENTS AMONG A NETWORK OF OFFICE-BASED ONCOLOGISTS IN GERMANY

Posterbeitrag DGHO 2020

The need for psycho-oncological support in colorectal cancer patients during different treatment phases

Posterbeitrag DKK 2020

The Need For Psycho-Oncological Support in Breast Cancer Patients - a Longitudinal Study in an Outpatient-Setting

Christian M. Kurbacher, Ralf Reichelt and Roland Schnell, DOI: 10.1200/jco.2015.33.15_suppl.e20565 Journal of Clinical Oncology 33, no. 15_suppl

(Link)

Real-world use and acceptance of rituximab biosimilars in non-Hodgkin lymphoma in an oncologist network in Germany

Otremba, Borchardt, Kuske, Hollnagel-Schmitz & Losch, Future Oncology, 10.2217/fon-2020-0180

(Link)

STEIGENDE NUTZUNG UND AKZEPTANZ VON RITUXIMAB BIOSIMILARS IN EINEM NETZWERK NIEDERGELASSENER ONKOLOGEN

Posterbeitrag DGHO 2019

STEIGENDE NUTZUNG UND AKZEPTANZ VON RITUXIMAB BIOSIMILARS IN EINEM NETZWERK NIEDERGELASSENER ONKOLOGEN
Posterbeitrag DKK 2018

 

Development of psychooncological stress in breast cancer patients –
a longitudinal study

Posterbeitrag, DKK 2016

 

The need for psychooncological support in breast cancer patients –
a longitudinal study

Posterbeitrag, MASCC 2015

 

Psychoonkologische Belastung von ambulant chemotherapierten Tumorpatienten

Posterbeitrag, DKK 2014